Bicocca Open Archive

Logo unimib boa
BIONDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 56.109
AS - Asia 28.352
EU - Europa 24.981
SA - Sud America 4.376
AF - Africa 477
Continente sconosciuto - Info sul continente non disponibili 53
OC - Oceania 49
Totale 114.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 54.858
SG - Singapore 9.917
CN - Cina 6.701
IT - Italia 5.528
HK - Hong Kong 4.754
RU - Federazione Russa 4.302
VN - Vietnam 3.874
BR - Brasile 3.571
DE - Germania 3.178
SE - Svezia 2.976
IE - Irlanda 2.715
UA - Ucraina 1.743
GB - Regno Unito 1.330
CA - Canada 906
FI - Finlandia 699
FR - Francia 618
IN - India 581
ID - Indonesia 482
KR - Corea 475
AT - Austria 425
TR - Turchia 357
NL - Olanda 327
AR - Argentina 323
BD - Bangladesh 252
MX - Messico 224
ZA - Sudafrica 221
PL - Polonia 217
JP - Giappone 209
DK - Danimarca 202
BE - Belgio 158
ES - Italia 155
EC - Ecuador 130
IQ - Iraq 121
CO - Colombia 89
PK - Pakistan 86
VE - Venezuela 71
SA - Arabia Saudita 62
IR - Iran 59
CH - Svizzera 58
EG - Egitto 58
AE - Emirati Arabi Uniti 55
PY - Paraguay 53
LT - Lituania 51
UZ - Uzbekistan 51
CZ - Repubblica Ceca 48
MA - Marocco 47
PE - Perù 44
CL - Cile 42
BG - Bulgaria 41
AU - Australia 38
EU - Europa 38
RO - Romania 36
KE - Kenya 33
IL - Israele 32
GR - Grecia 31
PH - Filippine 31
KZ - Kazakistan 30
JO - Giordania 29
UY - Uruguay 29
TN - Tunisia 28
AZ - Azerbaigian 26
NO - Norvegia 22
AL - Albania 21
JM - Giamaica 20
MY - Malesia 20
PA - Panama 20
PT - Portogallo 19
DO - Repubblica Dominicana 18
DZ - Algeria 18
NP - Nepal 18
TW - Taiwan 18
LB - Libano 17
BO - Bolivia 16
OM - Oman 16
KG - Kirghizistan 13
LV - Lettonia 13
CR - Costa Rica 12
HN - Honduras 12
SN - Senegal 12
TH - Thailandia 12
GT - Guatemala 11
NZ - Nuova Zelanda 10
AM - Armenia 9
NG - Nigeria 9
BA - Bosnia-Erzegovina 8
CI - Costa d'Avorio 8
ET - Etiopia 8
HR - Croazia 8
HU - Ungheria 8
RS - Serbia 8
TT - Trinidad e Tobago 8
A2 - ???statistics.table.value.countryCode.A2??? 7
NI - Nicaragua 7
PS - Palestinian Territory 7
SC - Seychelles 7
SK - Slovacchia (Repubblica Slovacca) 7
LK - Sri Lanka 6
BH - Bahrain 5
BY - Bielorussia 5
EE - Estonia 5
Totale 114.293
Salva come PNG Salva come JPEG
Città #
Ann Arbor 8.965
Singapore 5.920
Hong Kong 4.731
Ashburn 4.712
Woodbridge 4.520
Fairfield 4.226
Houston 3.561
Chandler 2.783
Dublin 2.617
Wilmington 2.440
Frankfurt am Main 1.989
Jacksonville 1.841
Seattle 1.728
Milan 1.515
Cambridge 1.460
New York 1.408
Dearborn 1.266
Santa Clara 1.198
Ho Chi Minh City 1.162
Beijing 1.133
Princeton 1.003
Hefei 946
Hanoi 909
Los Angeles 859
Dallas 824
Nanjing 528
Lawrence 474
Chicago 469
Altamura 459
Moscow 454
Seoul 446
Shanghai 435
Jakarta 378
Buffalo 357
São Paulo 337
Vienna 321
Lachine 309
The Dalles 295
San Diego 284
Munich 274
London 215
Guangzhou 209
Dong Ket 200
Rome 197
Helsinki 194
Toronto 180
Nuremberg 177
Boardman 175
Warsaw 168
Andover 166
Council Bluffs 161
Tokyo 158
Lissone 154
Nanchang 153
Brussels 146
Changsha 144
Montreal 141
Denver 136
Brooklyn 132
Rio de Janeiro 132
Shenyang 131
Hebei 128
Tianjin 127
Johannesburg 115
Stockholm 115
Salt Lake City 111
Monza 106
Turku 104
Jinan 102
Haiphong 96
Ottawa 96
Poplar 93
Chennai 90
Hangzhou 88
Da Nang 87
Phoenix 87
Fremont 86
Norwalk 85
Orem 84
Falls Church 82
Atlanta 81
Boston 80
Jiaxing 80
Lappeenranta 79
Ha Long 78
Brasília 77
Zhengzhou 75
Fuzhou 74
Mexico City 74
Tampa 72
Turin 72
Biên Hòa 71
Bologna 69
Pune 69
Kent 65
Mumbai 63
Hải Dương 62
Manchester 62
Quận Bình Thạnh 62
San Francisco 62
Totale 76.314
Salva come PNG Salva come JPEG
Nome #
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 499
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 462
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 452
BEYOND THE TUMOUR: CHILDHOOD CANCER PREDISPOSING SYNDROMES [Guardare oltre il tumore: le cancer-predisposingsyndrome in età pediatrica] 451
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 447
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 443
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels 442
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing 436
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 428
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 424
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 419
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 411
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 407
Acute myeloid leukaemia niche regulates response to L-asparaginase 403
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 398
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 392
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 391
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 388
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 387
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 383
NIPBL: a new player in myeloid cells differentiation 383
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 374
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 371
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 367
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 366
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 358
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 355
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 352
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 351
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 348
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 348
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 346
Studio preliminare sul profilo emotivo di un campione di bambini guariti da leucemia linfoblastica acuta 341
Moral distress in nurses in oncology and haematology units 340
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 337
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 335
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 334
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 331
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 328
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 323
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 319
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 318
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 317
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 316
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 315
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 315
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 314
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 313
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 312
Globalization of pediatric research: Pharmacological RCTs in Latin America 312
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 311
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 309
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 309
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 309
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 308
A second update on mapping the human genetic architecture of COVID-19 304
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 304
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 303
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 303
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 302
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 300
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 300
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals 299
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 296
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 296
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 295
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 295
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 294
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 294
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 293
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 291
Mapping the human genetic architecture of COVID-19 291
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 288
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 287
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 285
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 282
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 281
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 281
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 280
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 280
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 277
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 276
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 274
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 273
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 273
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 271
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 271
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 271
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 271
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia 268
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 266
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 265
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 264
An immune-based biomarker signature is associated with mortality in COVID-19 patients 264
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 263
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 262
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 262
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 261
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 261
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 259
Totale 32.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 395.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 395.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.100 0 0 0 0 0 1.045 1.103 1.075 915 1.207 725 1.030
2021/20227.503 529 839 954 528 429 516 350 389 572 540 597 1.260
2022/202311.443 1.435 3.409 836 1.011 707 1.702 194 681 748 95 410 215
2023/20248.951 310 290 438 479 1.139 2.268 1.640 318 756 190 282 841
2024/202522.169 1.151 2.332 1.267 1.023 1.856 899 1.489 801 2.275 3.119 1.990 3.967
2025/202627.706 6.909 3.803 3.936 6.022 6.404 632 0 0 0 0 0 0
Totale 117.363